AC-203

· TWi Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-203, covering 2019-04-16 to 2019-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients [Phase 2]